{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/60585b1d2385e843e03a5b94/6a42c3115a160c9d645c48a2?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"1 in 8 Americans On Ozempic. And It's Just Beginning ","description":"<p>30 million Americans are quietly getting thinner, and it's not through discipline or willpower. It's a weekly injection derived from the saliva of a Gila monster lizard. Welcome to the Ozempic revolution.</p><p>In part one of a two-part series, Alex and John dig into the GLP-1 drug phenomenon that's reshaping bodies, brains, and culture at a speed no diet trend ever has. From the Danish pharmaceutical company that accidentally broke its own stock exchange, to the celebrities suspiciously crediting \"lifestyle changes\" for dramatic weight loss, to the uncomfortable question of what these drugs mean for the body positivity movement, this is way bigger than weight loss.</p><p>They also revisit the original cutting-edge weight loss technology: Light and Easy frozen meals, a bag of South Australian marijuana, and absolutely no self-control.</p><p>Topics covered: Ozempic, Wegovy, semaglutide, GLP-1 drugs, weight loss drugs 2024, body positivity, Novo Nordisk, celebrity weight loss, Lizzo, Mindy Kaling, Megan Trainor, Wegovy ads, food culture, diet culture history</p><p>Don't Praise The Machine is a weekly comedy podcast about the ways culture is shifting, hosted by two old friends from opposite sides of the world.</p><p>New episodes every week. Subscribe so you don't miss part two.</p>","author_name":"Alexander Holland & John Maloney"}